Advanced Medical Isotope Corporation (RDGL)

Last Closing Price: --

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Advanced Medical Isotope Corporation (RDGL) had Net Income of $-2.91M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$0.03M
Net Income
$-2.91M
$0.03M
$-0.00M
$2.63M
$-2.60M
$-0.31M
$-2.91M
$-2.91M
$-2.91M
$-2.91M
$-2.91M
$-2.91M
$-2.60M
$-2.60M
409.67M
409.67M
$-0.01
$-0.01
Balance Sheet Financials
$2.23M
--
--
$2.23M
$0.09M
--
--
$0.09M
$-7.20M
$2.15M
$2.15M
440.87M
Cash Flow Statement Financials
$-1.68M
--
$2.30M
$1.59M
$2.21M
$0.62M
$1.01M
--
--
Fundamental Metrics & Ratios
25.91
--
--
--
--
-10.66%
-9303.03%
-9303.03%
-9303.03%
-10396.31%
-10396.31%
$-1.68M
--
--
--
0.01
--
2.71
134.63
40.41%
-135.54%
-130.31%
-135.54%
$0.00
$-0.00
$-0.00